These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11965297)

  • 21. Prostate cancer screening.
    Mayo Clin Health Lett; 1998 Nov; 16(11):1-3. PubMed ID: 9809017
    [No Abstract]   [Full Text] [Related]  

  • 22. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland.
    Carsin AE; Drummond FJ; Black A; van Leeuwen PJ; Sharp L; Murray LJ; Connolly D; Egevad L; Boniol M; Autier P; Comber H; Gavin A
    Cancer Causes Control; 2010 Sep; 21(9):1523-31. PubMed ID: 20514514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer rates climbed sharply in 1990.
    Reynolds T
    J Natl Cancer Inst; 1993 Jun; 85(12):947-8. PubMed ID: 7684455
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostate cancer screening; is this a teachable moment?
    Brawley OW
    J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970
    [No Abstract]   [Full Text] [Related]  

  • 26. Prostate cancer: is the PSA test the answer?
    Berlin B
    N J Med; 1998 Mar; 95(3):53-5. PubMed ID: 16013148
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of Metastatic Prostate Cancer On the Rise.
    Broderick JM
    Oncology (Williston Park); 2020 Nov; 34(11):460. PubMed ID: 33206985
    [No Abstract]   [Full Text] [Related]  

  • 28. Interpreting recent trends in prostate cancer incidence and mortality.
    Gann PH
    Epidemiology; 1997 Mar; 8(2):117-20. PubMed ID: 9229198
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessing risk: does this patient have prostate cancer?
    Carter HB
    J Natl Cancer Inst; 2006 Apr; 98(8):506-7. PubMed ID: 16622114
    [No Abstract]   [Full Text] [Related]  

  • 30. Latest UK figures show increase in prostate cancer diagnoses and falling death rate.
    Mayor S
    BMJ; 2012 May; 344():e3252. PubMed ID: 22569872
    [No Abstract]   [Full Text] [Related]  

  • 31. Why prostate cancer screening is necessary.
    Witte MN; Lindaman BD; Rosinsky DE
    S D Med; 2015; Spec No():88-91. PubMed ID: 25985616
    [No Abstract]   [Full Text] [Related]  

  • 32. What is the value of screening for prostate cancer in the US?
    Albertsen PC
    Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077
    [No Abstract]   [Full Text] [Related]  

  • 33. What happens to older men after a screening test for prostate cancer?
    BMJ; 2013 Apr; 346():f2421. PubMed ID: 23596225
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies.
    Parekh DJ; Ankerst DP; Thompson IM
    J Natl Cancer Inst; 2007 Apr; 99(7):496-7. PubMed ID: 17405989
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis and treatment of patients with prostate cancer: the nurse's role.
    Turner B
    Nurs Stand; 2007 Jun 6-12; 21(39):48-56; quiz 58. PubMed ID: 17569378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer and prostate-specific antigen: facts, figures and commentary.
    Chambers DC
    J Insur Med; 1993; 25(3):336-40. PubMed ID: 10146433
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiology of prostate cancer (cohort study)].
    Merabishvili VM; Petrova NG; Atroshchenko AV; Kharitonov MV
    Vopr Onkol; 2014; 60(4):457-63. PubMed ID: 25552064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of screening on prostate cancer rates and trends.
    Mettlin C
    Microsc Res Tech; 2000 Dec; 51(5):415-8. PubMed ID: 11074610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.